(Q36188441)

12 August 2017

1 reference

title

Prostacyclin signaling in the kidney: implications for health and disease (English)

1 reference

12 August 2017

Rania Nasrallah

1

1 reference

12 August 2017

Richard L Hébert

series ordinal

2

1 reference

12 August 2017

language of work or name

1 reference

1 August 2005

1 reference

American Journal of Physiology - Renal Physiology

12 August 2017

published in

1 reference

12 August 2017

volume

289

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

F235-46

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

12 August 2017

1 reference

Thromboxane and prostacyclin differentially regulate murine extracellular matrix gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Role of prostacyclin in the cardiovascular response to thromboxane A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Agonists can discriminate between cloned human and mouse prostacyclin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Protein kinase A-dependent coupling of mouse prostacyclin receptors to Gi is cell-type dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Prostacyclin receptor-mediated activation of extracellular signal-regulated kinases 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Discovery and SAR development of 2-(phenylamino) imidazolines as prostacyclin receptor antagonists [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

New developments on thromboxane and prostacyclin modulators part II: prostacyclin modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Eicosanoids in the pathogenesis of the functional and structural alterations of the kidney in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Diabetic nephropathy: renal development gone awry?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

COX-2-derived prostacyclin confers atheroprotection on female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Bradykinin-induced reductions in collagen gene expression involve prostacyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Role of extracellular cysteine residues in dimerization/oligomerization of the human prostacyclin receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Peroxisome proliferator-activated receptor delta activation promotes cell survival following hypertonic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Decreased vascular prostacyclin in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Lysophosphatidylcholine inhibits the expression of prostacyclin stimulating factor in cultured vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Prostaglandin synthesis in isolated rat kidney glomeruli

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Prostacyclin-dependent apoptosis mediated by PPAR delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

The prostacyclin receptor is isoprenylated. Isoprenylation is required for efficient receptor-effector coupling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Nuclear prostaglandin receptors: role in pregnancy and parturition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Activation of gene transcription by prostacyclin analogues is mediated by the peroxisome-proliferators-activated receptor (PPAR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Enhanced Therapeutic Angiogenesis by Cotransfection of Prostacyclin Synthase Gene or Optimization of Intramuscular Injection of Naked Plasmid DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Cyclooxygenase-2 inhibits tumor necrosis factor alpha-mediated apoptosis in renal glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Evidence that fibroblasts derive from epithelium during tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Enhancement of prostacyclin synthesis at the beginning of formation of caprine corpora lutea

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Localization of the prostacyclin receptor in human kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Protein kinase A-mediated phosphorylation of serine 357 of the mouse prostacyclin receptor regulates its coupling to G(s)-, to G(i)-, and to G(q)-coupled effector signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Transcriptional repression of atherogenic inflammation: modulation by PPARdelta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Dancing with different partners: protein kinase a phosphorylation of seven membrane-spanning receptors regulates their G protein-coupling specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

A novel pathway of prostacyclin signaling-hanging out with nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

The nuclear receptor superfamily: the second decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Investigation of the mechanisms of G protein: effector coupling by the human and mouse prostacyclin receptors. Identification of critical species-dependent differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Altered pain perception and inflammatory response in mice lacking prostacyclin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Characterization of the PGI2/IP system in cultured rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Localization of IP in rabbit kidney and functional role of the PGI(2)/IP system in cortical collecting duct

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Catheter-based prostacyclin synthase gene transfer prevents in-stent restenosis in rabbit atheromatous arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Unexpected news in renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Prostacyclin and its analogues in the treatment of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Prostaglandins protect kidneys against ischemic and toxic injury by a cellular effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Building a better aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

COX-2 compensation in the uterus of COX-1 deficient mice during the pre-implantation period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Direct toxicity of nonsteroidal antiinflammatory drugs for renal medullary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Cloning and expression of a cDNA for rat prostacyclin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

CNS-specific prostacyclin ligands as neuronal survival-promoting factors in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

COX-3--a virtual pain target in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Human prostacyclin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Phosphorylation of the prostacyclin receptor during homologous desensitization. A critical role for protein kinase c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Inhibition of lipopolysaccharide-stimulated TNF-alpha promoter activity by S-adenosylmethionine and 5'-methylthioadenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Antimitogenesis linked to regulation of Skp2 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Repeated gene transfer of naked prostacyclin synthase plasmid into skeletal muscles attenuates monocrotaline-induced pulmonary hypertension and prolongs survival in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

A novel subtype of the prostacyclin receptor expressed in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Essential role of Smad3 in the inhibition of inflammation-induced PPARbeta/delta expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Altered expression of prostacyclin synthase in a subset of the thick ascending limb cells and mesangial cells in 5/6-nephrectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Increased mRNA expression of a novel prostacyclin-stimulating factor in human colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Treprostinil for pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Gene expression of prostanoid forming enzymes along the rat nephron

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Dimerization of the human receptors for prostacyclin and thromboxane facilitates thromboxane receptor-mediated cAMP generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Focus on prostacyclin and its novel mimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Molecular mechanisms of diabetic renal hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Apoptosis and loss of renal tissue in polycystic kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Beraprost sodium, prostacyclin analogue, attenuates glomerular hyperfiltration and glomerular macrophage infiltration by modulating ecNOS expression in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Prostacyclin-deficient mice develop ischemic renal disorders, including nephrosclerosis and renal infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Renal fibrosis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

Role of connective tissue growth factor in renal tubular epithelial-myofibroblast transdifferentiation and extracellular matrix accumulation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00454.2004

10.1152/AJPRENAL.00454.2004

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference